| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELATOR PHARMACEUTICALS INC | 2,232,272 | 67,370,000 | 76.00% | ||
| 2 | Agile Therapeutics, Inc. | 1,580,491 | 12,028,000 | 13.57% | ||
| 3 | SYNTA PHARMACEUTICALS CORP | 21,770,662 | 5,665,000 | 6.39% | ||
| 4 | BERKSHIRE HATHAWAY INC DEL | 8,945 | 1,295,000 | 1.46% | ||
| 5 | CSW INDUSTRIALS INC COM | 11,253 | 367,000 | 0.41% | ||
| 6 | STELLUS CAP INVT CORP | 29,728 | 304,000 | 0.34% | ||
| 7 | CM FIN INC COM | 33,247 | 295,000 | 0.33% | ||
| 8 | PARATEK PHARMACEUTICALS INC | 18,909 | 263,000 | 0.30% | ||
| 9 | DOVER CORP | 3,224 | 223,000 | 0.25% | ||
| 10 | CIDARA THERAPEUTICS INC | 18,807 | 194,000 | 0.22% | ||
| 11 | MEDLEY CAP CORPORATION | 24,913 | 167,000 | 0.19% | ||
| 12 | American Capital Senior Floating Ltd | 15,255 | 157,000 | 0.18% | ||
| 13 | GARRISON CAP INC | 15,104 | 152,000 | 0.17% | ||
| 14 | Strongbridge Biopharma plc | 35,977 | 143,000 | 0.16% | ||
| 15 | SYNTA PHARMACEUTICALS CORP | 72,000 | 19,000 | 0.02% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-014769, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
